Joint Injections: Steroid, Gel, PRP and Image-Guided Treatment

Introduction

Joint injections are minimally invasive treatments used to reduce pain, improve mobility, and help patients return to daily activities when arthritis, inflammation, injury, or degeneration affects a joint. Depending on the diagnosis and treatment goal, an injection may contain corticosteroid medication, hyaluronic acid gel, platelet-rich plasma, or a combination of therapies.

Accuracy matters. Some injections can be performed safely in the office using ultrasound guidance, while deeper or more complex joints may be treated with ultrasound or fluoroscopic guidance at a procedure facility. Imaging allows the physician to visualize the target, avoid nearby structures, and confirm that the treatment is delivered into the intended joint.

Joint injections are not one-size-fits-all. The most appropriate treatment depends on the joint involved, the cause and severity of pain, imaging findings, prior treatments, medical history, and the patient’s goals. A corticosteroid injection may be selected to reduce inflammation, while hyaluronic acid or platelet-rich plasma may be considered when the goal is to improve longer-term joint function or address degenerative changes.

Quick Answer

Joint injections deliver medication, lubricating gel, or platelet-rich plasma directly into a painful joint. They may be performed with ultrasound guidance in the office or with ultrasound or fluoroscopic guidance at a procedure facility. Common options include corticosteroid injections for inflammation, hyaluronic acid injections for selected patients with osteoarthritis, platelet-rich plasma injections, and combination treatments such as PRP with hyaluronic acid. The best option depends on the joint being treated, the underlying diagnosis, and the patient’s individual goals.

Clinical Perspective

A joint injection should not be selected simply because a joint appears arthritic on an X-ray or MRI. Imaging abnormalities are common, and not every abnormality is responsible for a patient’s pain.

The essential question is:

Is the joint truly the primary source of pain, and which injectable treatment best matches the underlying condition?

A careful evaluation should consider the patient’s symptoms, physical examination, imaging findings, prior response to treatment, and whether pain may instead arise from a tendon, bursa, muscle, nerve, or referred source. Accurate diagnosis is what transforms an injection from a generic shot into a targeted treatment.

What Are Joint Injections?

A joint injection is a minimally invasive procedure in which medication, lubricating gel, platelet-rich plasma, or another therapeutic preparation is delivered directly into a joint. The goal may be to reduce inflammation, relieve pain, improve movement, or help determine whether the joint is the primary source of symptoms.

Joint injections are commonly considered when pain persists despite activity modification, physical therapy, exercise, medications, bracing, or other conservative treatments. They may also be used when pain is interfering with walking, work, sleep, exercise, or routine daily activities.

The procedure selected depends on the diagnosis. An inflamed joint may respond to a corticosteroid injection, while a patient with osteoarthritis may be considered for hyaluronic acid or platelet-rich plasma. In selected cases, PRP and hyaluronic acid may be used together as a combination treatment.

Which Joints Can Be Treated?

Image-guided injections can be performed in many joints throughout the body, including:

  • Knee
  • Hip
  • Shoulder
  • Elbow
  • Wrist
  • Thumb and finger joints
  • Ankle
  • Foot and toe joints
  • Sacroiliac joint

The depth, size, and surrounding anatomy of each joint influence how the injection is performed. Superficial joints may be treated in the office using ultrasound guidance, while deeper joints may require fluoroscopy or ultrasound in a procedure facility.

Diagnostic and Therapeutic Injections

Some joint injections serve both a diagnostic and therapeutic purpose. If local anesthetic placed accurately inside a joint produces meaningful temporary relief, that response may support the joint as a significant pain generator. A therapeutic medication may then provide longer-lasting improvement, depending on the condition being treated.

Key Point

A joint injection is not simply a treatment placed near the painful area. Image guidance helps confirm that the needle and injectate reach the intended joint, which is especially important for deeper joints such as the hip and sacroiliac joint.

Ultrasound-Guided vs Fluoroscopic Joint Injections

Image guidance helps the physician visualize the target, plan a safe needle path, and confirm that treatment is delivered into the intended joint. The two most commonly used forms of guidance are ultrasound and fluoroscopy.

Neither method is automatically superior for every injection. The most appropriate approach depends on the joint being treated, its depth, surrounding anatomy, the purpose of the procedure, the patient’s body habitus, and whether contrast confirmation is useful.

Ultrasound-Guided Joint Injections

Ultrasound uses real-time sound-wave imaging to display the joint, needle, muscles, tendons, blood vessels, and other nearby soft tissues. Because ultrasound does not use ionizing radiation, it is particularly useful for many office-based musculoskeletal procedures.

During an ultrasound-guided injection, the physician can watch the needle advance toward the joint and observe the medication or biologic preparation entering the intended region. Ultrasound may also identify fluid, synovial thickening, tendon abnormalities, bursitis, or other findings that help refine the diagnosis.

Ultrasound guidance is commonly used for injections involving the:

  • Knee
  • Shoulder
  • Elbow
  • Wrist
  • Thumb and finger joints
  • Ankle
  • Foot and toe joints
  • Selected hip and sacroiliac joint procedures

Fluoroscopic Joint Injections

Fluoroscopy is a form of real-time X-ray imaging. It is especially helpful when treating deep joints or when the physician wants to confirm intra-articular needle placement using a small amount of contrast material.

Under fluoroscopic guidance, the physician advances the needle while viewing the underlying bone structures. Contrast may then be injected to outline the joint space before the therapeutic medication is administered.

Fluoroscopy may be selected for procedures involving:

  • Deep hip joints
  • Sacroiliac joints
  • Selected shoulder injections
  • Other joints where bony landmarks and contrast confirmation are particularly useful

Office-Based vs Facility-Based Treatment

Many ultrasound-guided injections can be performed comfortably in the office using local anesthesia. This approach avoids radiation and allows the physician to evaluate the joint and nearby soft tissues during the same visit.

Some deeper or technically complex injections may be performed in a procedure facility using fluoroscopy or ultrasound. The facility setting may provide additional imaging equipment, procedural support, sterile preparation, monitoring, or sedation when medically appropriate.

Feature Ultrasound Guidance Fluoroscopic Guidance
Imaging Method Real-time sound-wave imaging Real-time X-ray imaging
Radiation None Uses a limited amount of ionizing radiation
Best Visualized Soft tissues, vessels, fluid, tendons, needle movement Bone landmarks, joint contours, and contrast spread
Typical Setting Often performed in the office Often performed in a procedure facility
Common Uses Superficial joints and soft-tissue evaluation Deep joints and procedures requiring contrast confirmation
Clinical Perspective

The imaging method should be selected for the patient and the target rather than by habit alone. Ultrasound provides excellent visualization of soft tissues without radiation, while fluoroscopy offers clear bony landmarks and the ability to confirm joint entry with contrast. Both can be highly accurate when used appropriately.

Types of Joint Injections

The substance placed into a joint should match the underlying diagnosis and the goal of treatment. Some injections are intended primarily to reduce inflammation, while others are used to improve joint lubrication or introduce biologically active components derived from the patient’s own blood.

The most appropriate option may vary according to the joint involved, the severity of degeneration, the presence of inflammation or fluid, previous treatments, medical conditions, insurance requirements, and the patient’s activity goals.

Corticosteroid Joint Injections

Corticosteroid injections, often called cortisone injections, are used to reduce inflammation inside a painful joint. They may be considered when arthritis, synovitis, or another inflammatory process is contributing to pain, swelling, and restricted movement.

A local anesthetic may be included to improve comfort and may provide temporary diagnostic information. Relief from the anesthetic generally occurs quickly, while the corticosteroid may take several days to reach its full effect.

The duration of improvement varies. Some patients experience meaningful relief, while others receive limited or temporary benefit. Repeated corticosteroid injections should be considered thoughtfully because frequency, timing, diabetes, anticoagulant use, infection risk, cartilage health, and anticipated surgery may influence the treatment plan.

Hyaluronic Acid or “Gel” Injections

Hyaluronic acid injections, also known as viscosupplementation or gel injections, introduce a gel-like material into the joint. Hyaluronic acid is naturally present within synovial fluid and contributes to lubrication and shock absorption.

Products such as Synvisc, Orthovisc, and Monovisc are used primarily for pain associated with osteoarthritis of the knee. These products differ in formulation and dosing schedule. Some are administered as a single injection, while others are given as a series.

Patient response varies, and professional guidelines do not uniformly recommend routine viscosupplementation for every person with knee osteoarthritis. It may nevertheless be considered selectively after discussion of the available evidence, prior treatment response, potential benefits, cost, and insurance coverage. FDA-cleared products such as Synvisc are indicated for knee osteoarthritis after inadequate response to conservative measures and simple analgesics. [Citation]

Platelet-Rich Plasma Injections

Platelet-rich plasma (PRP) is prepared from a sample of the patient’s own blood. The blood is processed to concentrate platelets and plasma, which contain growth factors and signaling proteins involved in healing and regulation of inflammation.

PRP is most commonly considered for selected patients with osteoarthritis or other degenerative joint conditions. It is not a stem-cell treatment, and it should not be described as regenerating an entire damaged joint. The goal is to improve pain and function by influencing the biological environment within and around the joint.

Studies of PRP for knee osteoarthritis have reported improvement in pain and function in selected patients, although results vary because preparation systems, platelet concentrations, injection schedules, disease severity, and study methods are not uniform. Current evidence does not support promising the same result for every patient or every joint. [Citation: AAOS]

PRP Combined With Hyaluronic Acid

In selected patients, PRP and hyaluronic acid may be administered together or as part of the same treatment plan. This approach combines the biologically active components of PRP with the lubricating and viscoelastic properties of hyaluronic acid.

Research examining combined PRP and hyaluronic acid treatment is evolving. Some studies in knee osteoarthritis have reported improvements in pain and function compared with hyaluronic acid alone, while the degree of added benefit over PRP alone remains less certain. Combination treatment should therefore be individualized rather than presented as automatically superior. [Citation: PubMed]

Joint Aspiration Before Injection

When a joint contains excess fluid, the physician may perform a joint aspiration before administering medication. Removing fluid may relieve pressure, improve movement, and allow the fluid to be examined when infection, gout, pseudogout, bleeding, or another inflammatory condition is suspected.

Aspiration and injection may occur during the same procedure when clinically appropriate. However, medication should not be injected when infection is suspected until the cause of the fluid has been adequately evaluated.

Injection Type Primary Goal Common Considerations
Corticosteroid Reduce inflammation and pain Often selected for an inflamed or painful joint; relief may be temporary
Hyaluronic Acid Supplement joint lubrication and cushioning Used primarily for selected patients with knee osteoarthritis
PRP Influence the joint’s biological and inflammatory environment Prepared from the patient’s blood; evidence and protocols vary
PRP + Hyaluronic Acid Combine biologic and viscoelastic treatment strategies Promising but evolving evidence; not automatically preferable for every patient
Clinical Perspective

There is no universally “best” joint injection. Corticosteroid, hyaluronic acid, PRP, and combination therapy serve different purposes and have different evidence, costs, timelines, and limitations. Treatment should be selected after identifying the painful structure and discussing realistic goals.

How Is a Joint Injection Performed?

The exact steps vary according to the joint being treated, the type of image guidance used, and whether the injection contains corticosteroid, hyaluronic acid, platelet-rich plasma, or a combination treatment. Most joint injections are brief outpatient procedures performed with local anesthesia.

Before the Procedure

The physician reviews the patient’s symptoms, examination findings, imaging studies, medications, allergies, and relevant medical conditions. Patients should report the use of blood-thinning medication, active infection, recent illness, poorly controlled diabetes, pregnancy, or a previous reaction to contrast material or injectable medications.

When platelet-rich plasma is planned, specific preparation instructions may be provided regarding anti-inflammatory medications, hydration, food intake, and activity. These recommendations may differ from those used before a corticosteroid or gel injection.

Positioning and Sterile Preparation

The patient is positioned so the physician can comfortably access the targeted joint. The skin is cleaned with an antiseptic solution, and sterile technique is used to reduce the risk of infection.

A small amount of local anesthetic may be administered to numb the skin and deeper tissues. For some superficial injections, only minimal numbing medication may be necessary.

Image-Guided Needle Placement

The physician uses ultrasound or fluoroscopy to identify the joint and guide the needle along a safe path. With ultrasound, the needle and nearby soft tissues can be viewed in real time. With fluoroscopy, the physician follows the bony landmarks and may inject a small amount of contrast material to confirm that the needle has entered the joint.

When excess joint fluid is present, aspiration may be performed before the therapeutic injection. The fluid may be discarded or sent for laboratory analysis when infection, gout, pseudogout, bleeding, or another inflammatory condition is suspected.

Delivery of the Injection

Once accurate needle placement has been confirmed, the selected treatment is slowly introduced into the joint. Depending on the treatment plan, this may include:

  • Corticosteroid with or without local anesthetic
  • Hyaluronic acid gel
  • Platelet-rich plasma
  • PRP combined with hyaluronic acid

The needle is then removed, and a small bandage is placed over the injection site. Most patients are able to leave shortly afterward.

How Long Does the Procedure Take?

Many office-based injections take approximately 10 to 20 minutes, although additional time may be required for evaluation, preparation, aspiration, PRP processing, fluoroscopic imaging, or recovery after the procedure.

Key Point

The purpose of image guidance is not merely to photograph the procedure. It allows the physician to identify the target, monitor the needle path, avoid important surrounding structures, and confirm accurate treatment delivery.

Recovery After a Joint Injection

Most patients return home shortly after a joint injection. Recovery is usually brief, but the recommended activity level and expected timeline vary depending on the joint treated and whether the injection contains corticosteroid, hyaluronic acid, platelet-rich plasma, or combination therapy.

Immediately After the Procedure

Temporary numbness or heaviness may occur when local anesthetic is used. Patients should move carefully until normal sensation and strength have returned, particularly after an injection involving a weight-bearing joint such as the hip, knee, ankle, or foot.

Mild soreness, pressure, or swelling around the injection site may develop during the first day or two. A cold pack may be applied intermittently, provided the skin is protected from direct contact with ice.

Activity After the Injection

Light daily activity is generally acceptable after many joint injections. Strenuous exercise, heavy lifting, repetitive joint loading, and high-impact activity are commonly limited for approximately 24 to 48 hours, although instructions may differ according to the procedure and the patient’s condition.

Patients receiving hyaluronic acid injections into the knee are often advised to avoid prolonged weight-bearing and strenuous activities for about 48 hours. [Citation: FDA Access Data]

When Will Relief Begin?

The onset of improvement depends on the treatment used:

  • Local anesthetic: May provide relief within minutes, but the effect is temporary.
  • Corticosteroid: Improvement may begin within several days, although a brief increase in discomfort can occur before the medication takes effect.
  • Hyaluronic acid: Improvement is usually gradual and may take several weeks.
  • PRP: Temporary soreness may occur initially, with improvement developing gradually over several weeks or months.
  • PRP with hyaluronic acid: The response varies, and improvement is generally assessed over the following weeks rather than immediately.

Not every injection produces meaningful relief. The degree and duration of improvement depend on the diagnosis, severity of joint damage, treatment selected, accuracy of placement, rehabilitation, and individual biological response.

Medication Instructions

Patients should follow the specific medication instructions provided by the treating physician. Recommendations may differ after corticosteroid, gel, and PRP injections.

After PRP, patients may be advised to temporarily avoid nonsteroidal anti-inflammatory medications because these drugs may interfere with aspects of the intended inflammatory and healing response. Acetaminophen or another permitted medication may be recommended when pain control is needed.

When to Contact the Physician

Mild soreness after an injection is common. Patients should contact the treating office promptly if they develop:

  • Increasing redness, warmth, or swelling
  • Fever or chills
  • Severe or rapidly worsening pain
  • Persistent drainage from the injection site
  • A new rash, facial swelling, or difficulty breathing
  • Progressive numbness, weakness, or inability to bear weight

Pain, swelling, redness, and fluid accumulation are recognized possible reactions after hyaluronic acid injections, although serious complications remain uncommon. [Citation: FDA Access Data]

Key Point

An injection is only one part of treatment. Long-term improvement may also depend on rehabilitation, strengthening, weight management, activity modification, and treatment of the underlying joint condition.

Risks and Possible Side Effects of Joint Injections

Joint injections are generally well tolerated when performed using sterile technique and appropriate image guidance. However, every procedure carries potential risks, and the type of injection used may introduce additional considerations.

The likelihood of a complication depends on the joint being treated, the medication or biologic preparation selected, the patient’s medical history, and the number and frequency of previous injections.

Common Temporary Reactions

Temporary discomfort around the injection site is relatively common and usually improves within a few days. Possible short-term reactions include:

  • Pain or soreness at the injection site
  • Mild swelling or stiffness
  • Temporary bruising
  • A brief increase in joint pain
  • Temporary numbness when local anesthetic is used
  • Lightheadedness or a vasovagal reaction

Infection

Infection within a joint, known as septic arthritis, is uncommon but potentially serious. Sterile skin preparation, sterile equipment, and careful procedural technique are used to reduce this risk.

Patients should promptly report increasing redness, warmth, swelling, fever, drainage, or rapidly worsening pain after an injection.

Bleeding and Bruising

Minor bruising may occur where the needle enters the skin. The risk of more significant bleeding may be higher in patients taking anticoagulants, antiplatelet medications, or those with a bleeding disorder.

Patients should not stop prescribed blood-thinning medication unless specifically instructed by the prescribing and treating physicians.

Temporary Increase in Blood Sugar

Corticosteroid injections may temporarily increase blood glucose levels, particularly in patients with diabetes. Patients who monitor their blood sugar may be advised to check it more frequently after the procedure and contact the clinician managing their diabetes if readings become significantly elevated. [oai_citation:0‡OrthoInfo](https://orthoinfo.aaos.org/en/treatment/cortisone-shot-steroid-injection/?utm_source=chatgpt.com)

Steroid Flare

Some patients experience a temporary increase in pain and inflammation after a corticosteroid injection. This reaction, sometimes called a steroid flare, usually begins within the first day and improves over the following several days.

Cartilage and Tissue Effects

Repeated corticosteroid injections may affect cartilage and nearby soft tissues. For this reason, the frequency and timing of injections should be individualized rather than scheduled automatically.

The physician may also consider whether joint replacement or another surgery is anticipated, because the timing of a corticosteroid injection before surgery can influence treatment planning.

Hyaluronic Acid Reactions

Hyaluronic acid injections may cause temporary pain, swelling, warmth, stiffness, or fluid accumulation in the treated knee. More intense inflammatory reactions can occur but are uncommon. FDA product information lists injection-site pain and joint swelling or effusion among reported adverse events. [Citation: FDA Access Data]

PRP-Related Reactions

Because PRP is prepared from the patient’s own blood, allergic reactions are uncommon. Temporary soreness, swelling, and stiffness may occur as part of the inflammatory response following treatment.

PRP still carries the general procedural risks of needle placement, including infection, bleeding, bruising, and injury to nearby structures.

Allergic or Contrast Reactions

Allergic reactions to medications, antiseptic preparations, dressings, or contrast material are uncommon. Patients should tell the physician about previous reactions to injectable medications, iodine-based contrast, adhesives, chlorhexidine, or latex.

Injury to Nearby Structures

Nerves, blood vessels, tendons, and other soft tissues may lie close to the treatment path. Ultrasound or fluoroscopic guidance helps the physician visualize relevant anatomy and select a safer needle trajectory.

Clinical Perspective

The decision to repeat an injection should be based on the diagnosis, the degree and duration of prior benefit, the treatment used, and the patient’s overall health. A procedure that provided little meaningful relief should not simply be repeated out of habit.

Who May Be a Candidate for a Joint Injection?

Joint injections may be considered when pain, stiffness, swelling, or reduced mobility persists despite appropriate conservative treatment. The decision depends on the diagnosis, the joint involved, symptom severity, imaging findings, previous treatment response, and the patient’s overall health.

An injection is most useful when the painful joint has been identified with reasonable confidence. Pain arising from a tendon, bursa, muscle, nerve, or referred spinal condition may require a different treatment.

Common Reasons to Consider a Joint Injection

  • Osteoarthritis causing persistent pain or reduced function
  • Inflammatory irritation within a joint
  • Joint swelling or synovitis
  • Pain that limits walking, exercise, work, sleep, or daily activities
  • Incomplete relief from physical therapy, medications, bracing, or activity modification
  • A need to determine whether a particular joint is the primary source of pain
  • A desire to postpone or avoid surgery when clinically reasonable
  • Persistent symptoms after a previous treatment that provided only partial or temporary relief

Choosing Among Steroid, Gel, and PRP

The most appropriate injection depends on the clinical goal. Corticosteroid may be considered when inflammation is prominent and relatively rapid relief is desired. Hyaluronic acid may be discussed for selected patients with knee osteoarthritis, particularly when other conservative treatments have not provided sufficient relief.

PRP may be considered for selected patients with degenerative joint pain who prefer a biologic treatment derived from their own blood. Combined PRP and hyaluronic acid may also be discussed in appropriate cases, although the evidence continues to evolve.

Age alone does not determine candidacy. The severity and pattern of arthritis, mechanical alignment, joint stability, activity level, medical history, expectations, and prior response to treatment are often more important.

When an Injection May Be Postponed

A joint injection may need to be postponed when temporary medical circumstances could increase risk or interfere with treatment. These may include:

  • Active fever, illness, or suspected infection
  • Skin infection, open wound, or rash near the injection site
  • Poorly controlled blood glucose or another unstable medical condition
  • Recent vaccination, illness, or surgery when timing should be reviewed
  • Planned joint replacement or another operation involving the same joint
  • Use of anticoagulant or antiplatelet medication requiring individualized review
  • Pregnancy when fluoroscopy, contrast, or particular medications are being considered

Patients should not stop prescribed blood thinners without instructions from the clinicians managing those medications.

When a Joint Injection May Not Be Appropriate

An injection may not be recommended when the potential risks outweigh the expected benefit or when another treatment is more likely to address the underlying problem. Examples may include:

  • Suspected septic arthritis or infection elsewhere in the body
  • A fracture involving the target joint
  • Severe joint instability or advanced structural collapse
  • A known serious allergy to a required medication or product
  • A bleeding disorder that cannot be safely managed
  • Pain that is not primarily arising from the joint
  • Little or no meaningful benefit from repeated prior injections
  • A condition requiring urgent surgical or medical treatment

Special Considerations Before Corticosteroid Injection

Corticosteroid injections require additional planning in patients with diabetes because blood glucose may rise temporarily after treatment. The timing of an injection should also be reviewed when joint replacement surgery is anticipated. AAOS advises delaying replacement surgery in the injected joint for at least three months after a corticosteroid injection to help reduce infection risk. [Citation: OrthoInfo]

Clinical Perspective

The best candidate is not simply someone with an abnormal X-ray. A useful injection plan begins with a credible diagnosis, a clearly defined treatment goal, realistic expectations, and a discussion of how the procedure fits into the patient’s broader rehabilitation or arthritis-management strategy.

How Long Do Joint Injections Last?

The amount and duration of relief after a joint injection vary considerably. Some patients experience substantial improvement, while others notice only partial, temporary, or no meaningful benefit. Results depend on the diagnosis, severity of joint damage, treatment selected, accuracy of placement, activity level, rehabilitation, and individual biological response.

Joint injections generally help manage symptoms rather than reverse advanced arthritis or permanently restore damaged cartilage. Their value should be measured by meaningful improvements in pain, mobility, sleep, walking tolerance, exercise, work, and daily function.

Corticosteroid Injections

Local anesthetic may produce temporary relief within minutes or hours. The corticosteroid usually takes longer to work, with improvement commonly developing over the following several days.

Relief may last from several weeks to several months, although the response differs significantly among patients. Corticosteroid injections may be particularly useful when active inflammation is contributing to pain and swelling, but repeated injections can become less effective over time.

Hyaluronic Acid or Gel Injections

Improvement after hyaluronic acid is generally gradual rather than immediate. Some patients begin noticing reduced pain and improved function over several weeks.

The duration of benefit varies by patient and product. Clinical studies of certain single-injection hyaluronic acid products for knee osteoarthritis have evaluated symptom improvement for up to approximately six months. This does not mean every patient will experience six months of relief.

Platelet-Rich Plasma Injections

PRP commonly causes temporary soreness before improvement begins. Patients who respond may notice gradual changes over several weeks, with function and pain continuing to improve over the following months.

Some studies of knee osteoarthritis have reported benefits lasting six to twelve months in selected patients. However, PRP preparations, injection protocols, arthritis severity, and study methods vary considerably, so results cannot be predicted precisely for an individual patient.

PRP Combined With Hyaluronic Acid

Combination treatment is intended to unite the biological effects of PRP with the lubricating and viscoelastic properties of hyaluronic acid. Improvement, when it occurs, generally develops gradually over the following weeks.

Research remains evolving regarding whether combination therapy provides greater or longer-lasting relief than PRP alone. Treatment should therefore be individualized rather than selected solely because two products are being used together.

What Counts as a Successful Result?

Complete elimination of pain is not required for an injection to be clinically useful. A meaningful response may include:

  • Reduced pain during walking or exercise
  • Improved joint movement and flexibility
  • Greater tolerance for physical therapy
  • Reduced reliance on pain medication
  • Improved sleep
  • Greater ability to work or perform daily activities
  • Postponing more invasive treatment when medically appropriate

When Should an Injection Be Repeated?

Repeat treatment should be based on the degree and duration of prior benefit, the type of injection used, the condition of the joint, medical risk factors, and the patient’s broader treatment plan.

An injection that produced substantial functional improvement for a meaningful period may reasonably be considered again when symptoms return. In contrast, a treatment that provided little or no benefit should prompt reassessment of the diagnosis and treatment strategy rather than automatic repetition.

Clinical Perspective

The most useful question is not simply, “How long will the injection last?” It is whether the treatment creates enough improvement for the patient to move better, participate in rehabilitation, regain function, and advance the overall joint-management plan.

Frequently Asked Questions About Joint Injections

Are joint injections painful?

Most patients experience pressure, brief stinging, or temporary discomfort rather than severe pain. Local anesthetic may be used to numb the skin and deeper tissues. Image guidance can also reduce unnecessary needle movement by helping the physician visualize the target directly.

Do joint injections cure arthritis?

No. Joint injections may reduce pain, inflammation, or stiffness, but they do not reverse advanced arthritis or permanently restore damaged cartilage. Their purpose is to improve symptoms and function as part of a broader treatment plan.

Which joint injection is best?

There is no single injection that is best for every patient. Corticosteroid, hyaluronic acid, PRP, and combination therapy have different purposes, evidence, costs, timelines, and limitations. The most appropriate option depends on the diagnosis, joint involved, degree of degeneration, prior treatments, and the patient’s goals.

Are ultrasound-guided injections more accurate?

Ultrasound guidance allows the physician to visualize the joint, needle, fluid, tendons, blood vessels, and nearby soft tissues in real time. This can improve confidence in needle placement, especially when anatomy is difficult to identify using surface landmarks alone.

Why would fluoroscopy be used instead of ultrasound?

Fluoroscopy provides excellent visualization of bony anatomy and allows contrast material to confirm that the needle has entered the joint. It may be preferred for certain deep joints, technically complex targets, or procedures where contrast confirmation is particularly valuable.

Can joint fluid be removed during the same procedure?

Yes. When excess fluid is present, the physician may aspirate the joint before administering medication. The fluid may also be sent for laboratory analysis when infection, gout, pseudogout, bleeding, or another inflammatory condition is suspected.

How many corticosteroid injections can I receive?

There is no universal number that applies to every patient or joint. The decision should consider the amount and duration of previous relief, the health of the joint and surrounding tissues, diabetes, infection risk, anticipated surgery, and whether repeated treatment remains clinically useful.

Are gel injections used in every joint?

Hyaluronic acid products are used primarily for selected patients with knee osteoarthritis. Use in other joints may be considered in certain circumstances, but evidence, product labeling, and insurance coverage differ.

Is PRP the same as stem-cell therapy?

No. PRP is prepared from the patient’s blood and contains concentrated platelets and plasma. It is not a stem-cell treatment and should not be described as replacing an entire damaged joint or regrowing advanced cartilage loss.

Can PRP and hyaluronic acid be given together?

Yes, combination treatment may be considered in selected patients. The goal is to combine the biological activity of PRP with the lubricating properties of hyaluronic acid. Research is still developing regarding which patients benefit most and whether combination treatment consistently outperforms PRP alone.

Will I need sedation?

Most office-based joint injections do not require sedation. Local anesthetic is usually sufficient. Sedation may occasionally be considered for selected facility-based procedures, depending on the target, patient comfort, medical history, and procedural circumstances.

Can I drive after a joint injection?

Driving instructions depend on the joint treated, medications used, and whether sedation was administered. Patients should not drive if they experience temporary weakness, numbness, impaired movement, or receive medication that affects alertness.

Can I exercise after the injection?

Light activity is often permitted, but strenuous exercise, heavy lifting, and repetitive joint loading are commonly restricted for a brief period. The exact recommendation differs after corticosteroid, gel, PRP, and combination injections.

What happens if the injection does not help?

A lack of meaningful improvement may indicate advanced joint damage, an unsuitable treatment selection, or that the joint is not the primary pain generator. The diagnosis and treatment plan should be reassessed rather than automatically repeating the same procedure.

Are joint injections covered by insurance?

Coverage varies by insurer, diagnosis, medication, joint treated, and prior authorization requirements. Corticosteroid injections are commonly covered when medically appropriate. Hyaluronic acid coverage often requires documentation of knee osteoarthritis and prior conservative treatment. PRP and combination treatments are frequently considered self-pay services.

Key Point

The success of a joint injection depends on more than the substance being injected. Accurate diagnosis, appropriate patient selection, precise image-guided placement, realistic expectations, and follow-through with rehabilitation all influence the result.

Key Takeaways

  • Joint injections are minimally invasive treatments used to reduce pain, inflammation, stiffness, and functional limitations arising from selected joint conditions.
  • Ultrasound and fluoroscopy help confirm accurate needle placement and allow the physician to select a safe path to the targeted joint.
  • Corticosteroid injections, hyaluronic acid gel, platelet-rich plasma, and combined PRP with hyaluronic acid serve different purposes and should not be treated as interchangeable options.
  • Hyaluronic acid products are used primarily for selected patients with knee osteoarthritis, while PRP protocols and insurance coverage vary.
  • Joint aspiration may be performed when excess fluid is present or when infection, gout, pseudogout, or bleeding must be considered.
  • Most patients return home shortly after treatment, although activity and medication instructions differ according to the injection used.
  • Joint injections may improve pain and function, but they do not reverse advanced arthritis or permanently restore severely damaged cartilage.
  • A successful treatment plan begins with identifying whether the joint is truly the primary source of pain.

Considering a Joint Injection?

The first step is determining whether your symptoms are truly arising from the joint and which treatment best matches the diagnosis. At SpinePain Solutions, joint injections may be performed with ultrasound guidance in the office or with ultrasound or fluoroscopic guidance at a procedure facility, depending on the joint and clinical circumstances.

Treatment options may include corticosteroid, hyaluronic acid gel, platelet-rich plasma, or carefully selected combination therapy. Recommendations are individualized according to the joint involved, imaging findings, previous treatments, medical history, and functional goals.

Ready to Take The Next Step?
Book an appointment with
Dr. Amit Sharma & our minimally invasive pain & spine team.
Same-day and urgent appointments are often available.

References

  1. American Academy of Orthopaedic Surgeons. Management of Osteoarthritis of the Knee (Non-Arthroplasty): Evidence-Based Clinical Practice Guideline. 3rd ed. Published August 31, 2021.
  2. American Academy of Orthopaedic Surgeons. Platelet-Rich Plasma for Knee Osteoarthritis: Technology Overview.
  3. American Institute of Ultrasound in Medicine. Practice Parameter for the Performance of Selected Ultrasound-Guided Procedures.
  4. U.S. Food and Drug Administration. Synvisc-One: Summary of Safety and Effectiveness Data. PMA P940015/S012.
  5. Lin KY, Yang CC, Hsu CJ, Yeh ML, Renn JH. Intra-articular injection of platelet-rich plasma is superior to hyaluronic acid or saline solution in the treatment of mild to moderate knee osteoarthritis: a randomized, double-blind, triple-parallel, placebo-controlled clinical trial. Arthroscopy. 2019;35(1):106-117.
  6. Belk JW, Kraeutler MJ, Houck DA, Goodrich JA, Dragoo JL, McCarty EC. Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. American Journal of Sports Medicine. 2021;49(1):249-260.
  7. Szwedowski D, Szczepanek J, Paczesny Ł, et al. Intra-articular injection of platelet-rich plasma is more effective than hyaluronic acid or steroid injection in the treatment of mild to moderate knee osteoarthritis: a prospective randomized study. Biomedicines. 2022;10(5):991.
  8. Fossati C, et al. Efficacy of intra-articular combined platelet-rich plasma and hyaluronic acid compared with PRP or hyaluronic acid alone for knee osteoarthritis: a multicenter randomized controlled trial. 2024.
  9. Mai Y, et al. Efficacy of platelet-rich plasma combined with hyaluronic acid for moderate-to-severe knee osteoarthritis. Journal of Orthopaedic Surgery and Research. 2023.
  10. American Academy of Orthopaedic Surgeons. Cortisone Shot: Steroid Injection. OrthoInfo.
  11. American Academy of Orthopaedic Surgeons. Viscosupplementation Treatment for Knee Arthritis. OrthoInfo.
  12. American Academy of Orthopaedic Surgeons. Management of Osteoarthritis of the Hip: Evidence-Based Clinical Practice Guideline. 2023.

Medical Disclaimer

This article is provided for educational purposes only and is not a substitute for personal medical advice, diagnosis, or treatment. Joint pain may arise from arthritis, tendons, bursae, muscles, nerves, fractures, infection, referred spinal pain, or other conditions requiring different treatments. The appropriateness, risks, benefits, and expected results of any injection must be evaluated individually by a qualified healthcare professional.

Location Map:

Our Apps


APPatient App

Download on the App Store

Get it on Google Play
631-310-0000